Year |
Citation |
Score |
2009 |
Vandyck K, Cummings MD, Nyanguile O, Boutton CW, Vendeville S, McGowan D, Devogelaere B, Amssoms K, Last S, Rombauts K, Tahri A, Lory P, Hu L, Beauchamp DA, Simmen K, et al. Structure-based design of a benzodiazepine scaffold yields a potent allosteric inhibitor of hepatitis C NS5B RNA polymerase. Journal of Medicinal Chemistry. 52: 4099-102. PMID 19507864 DOI: 10.1021/jm9005548 |
0.314 |
|
2005 |
Verschueren WG, Dierynck I, Amssoms KI, Hu L, Boonants PM, Pille GM, Daeyaert FF, Hertogs K, Surleraux DL, Wigerinck PB. Design and optimization of tricyclic phtalimide analogues as novel inhibitors of HIV-1 integrase. Journal of Medicinal Chemistry. 48: 1930-40. PMID 15771437 DOI: 10.1021/jm049559q |
0.368 |
|
2002 |
Amssoms K, Oza SL, Augustyns K, Yamani A, Lambeir AM, Bal G, Van der Veken P, Fairlamb AH, Haemers A. Glutathione-like tripeptides as inhibitors of glutathionylspermidine synthetase. Part 2: substitution of the glycine part. Bioorganic & Medicinal Chemistry Letters. 12: 2703-5. PMID 12217358 DOI: 10.1016/S0960-894X(02)00538-3 |
0.464 |
|
2002 |
Amssoms K, Oza SL, Ravaschino E, Yamani A, Lambeir A, Rajan P, Bal G, Rodriguez J, Fairlamb AH, Augustyns K, Haemers A. Glutathione-like tripeptides as inhibitors of glutathionylspermidine synthetase. Part 1: Substitution of the glycine carboxylic acid group. Bioorganic & Medicinal Chemistry Letters. 12: 2553-6. PMID 12182858 DOI: 10.1016/S0960-894X(02)00489-4 |
0.463 |
|
Show low-probability matches. |